Softbank Vision Fund 2, ADM, Danone Manifesto Ventures and SK helped the microbial protein developer take its total funding above $500m.
Telecommunications and internet group SoftBank’s Vision Fund 2 led a $350m series C round for US-based alternative protein developer Nature’s Fynd yesterday. Food producer Danone’s corporate venturing arm, Danone Manifesto Ventures, also participated in the round, as did agribusiness Archer Daniels Midland (ADM) and conglomerate SK. The participants were completed by Blackstone Strategic Partners, Balyasny…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.